Table 4: Tumor
responses and adverse events
|
No. |
TR |
LR/M |
DM/M |
Skin ulcer Grade |
Alopecia Grade |
Survival M |
|
1 |
CR |
Yes/20 |
Lung/13 |
2 |
2 |
38.7 |
|
2 |
CR |
No |
Lung, Liver/10 |
3 |
2 |
13.1 |
|
3 |
CR |
No |
Neck/10 |
3 |
2 |
40.9 |
|
4 |
CR |
No |
Brain/36 |
3 |
2 |
86.3 |
|
5 |
CR |
No |
Lung/1 |
2 |
2 |
10.9 |
|
6 |
CR |
No |
Leg/11 |
2 |
2 |
19.8 |
|
7 |
CR |
No |
No |
2 |
2 |
46.6 |
|
8 |
CR |
No |
Bone/5 |
3 |
2 |
5.6 |
|
9 |
CR |
No |
No |
2 |
2 |
10.5 |
|
10 |
CR |
No |
No |
3 |
2 |
8.7 |
TR:
Tumor Response, LR: Local Relapse, M: Months, DM:
Distant Metastasis.
A
complete response (CR) was achieved in all patients (100%) and only 1 patient
suffered local relapse 20 months after RT.